Enrique Dilone was Appointed as Chief Technology Officer at ImmunityBio

Date of management change: August 03, 2023 

What Happened?

Culver City, CA-based ImmunityBio Appointed Enrique Dilone as Chief Technology Officer

 

About the Company

ImmunityBio is a vertically-integrated, clinical-stage biotechnology company developing next-generation therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. The company`s range of immunotherapy and cell therapy platforms, alone and together, act to drive and sustain an immune response with the goal of creating durable and safe protection against disease. We are applying our science and platforms to treating cancers, including the development of potential cancer vaccines, as well as developing immunotherapies and cell therapies that we believe sharply reduce or eliminate the need for standard high-dose chemotherapy. These platforms and their associated product candidates are designed to be more effective, accessible, and easily administered than current standards of care in oncology and infectious diseases.

 

About the Person

Enrique Dilone is Chief Technology Officer at ImmunityBio. Previously, Enrique held various senior IT leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Chan Daniel, Hartman Steven, Phillips Josh, Johnson Rick, Warren Galen, Jenkins Jonathan, Truedson Jeff, Brown Julie, Cochran Chris, Reeder Andrew, Fitzgerald Timothy

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.